Chemoattractants (Interleukin-8 and Leukotriene B4) did not increase either the expression or the amount of high-affinity CD11b/CD18-integrins in CAD patients compared to controls, and had no effect on the production of ROS. Here, ITGB2 is linked to coronary artery disorder.